查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1525999

光动力疗法（PDT）市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031年

Photodynamic Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024 - 2031
出版日期: | 出版商: Persistence Market Research | 英文 170 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球光动力疗法（PDT）市场的综合报告。本报告对基本市场动态进行了详细评估，包括市场驱动因素、趋势、机会和挑战，并对市场结构提供了深入的见解。

关键见解

  • 光动力疗法市场规模（2024年）：35亿美元
  • 预估市场规模（2031年）：74亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：7.1%

光动力治疗市场-报告范围：

光动力疗法在治疗多种疾病中发挥重要作用，包括某些癌症、老年黄斑部病变（AMD）和癌前病变。 PDT 使用光敏药物和特定波长的光来破坏目标细胞。光动力治疗市场为医院、肿瘤中心和眼科诊所提供服务，并提供各种治疗产品和技术，包括光敏剂、光源和传输系统。癌症和慢性病盛行率的增加、医疗保健投资的增加以及可提高治疗效果和患者预后的 PDT 技术的进步推动了市场成长。

推动市场成长的因素：

全球光动力治疗市场由几个关键因素推动，例如癌症和其他需要有效治疗方案的慢性疾病的盛行率不断增加。对非侵入性和标靶治疗的需求不断成长，以及光敏剂化合物和光传输系统的进步推动市场扩张。眼科领域日益采用 PDT 来治疗 AMD，以及开发具有提高疗效和减少副作用的新 PDT 药物也有助于市场扩张。此外，扩大医疗基础设施和增加 PDT 研究活动也为市场进入者创造了新的机会。

市场限制因素：

虽然光动力疗法市场有望实现成长，但它面临着治疗成本高、偿付范围有限和潜在副作用等挑战。对于某些医疗保健系统和患者来说，PDT 设备和光敏剂的成本可能过高，尤其是在医疗保健预算有限的新兴市场。此外，PDT 治疗的偿付有限以及对皮肤敏感和损伤等潜在副作用的担忧对市场渗透构成了挑战。解决这些障碍需要产业利益相关者、医疗保健提供者和政策制定者共同努力，以提高 PDT 解决方案的可近性和可负担性。

市场机会：

由于技术创新、人口趋势和不断发展的治疗模式，光动力治疗市场呈现出巨大的成长机会。具有增强特异性和降低全身毒性的先进光敏剂的开发提供了新的治疗可能性。此外，PDT与化疗、免疫疗法等其他治疗方法的结合日益扩大其应用范围。个人化医疗的兴起以及对早期疾病检测和治疗的兴趣日益浓厚，为 PDT 开闢了新的途径。研发方面的策略性投资、策略联盟以及引进具有成本效益的 PDT 解决方案对于利用新机会和维持市场领先地位非常重要。

本报告涵盖的主要问题

  • 推动全球光动力治疗市场成长的关键因素是什么？
  • 哪些 PDT 应用和技术引领各个医疗领域的采用？
  • 技术进步与创新如何改变 PDT 市场的竞争格局？
  • 谁是光动力疗法市场的主要公司？ 他们采取了哪些策略来维持其在市场上的地位？
  • 全球光动力治疗市场的新趋势与未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 主要市场趋势

  • 疾病流行病学（2019）
  • 患者治疗过程
  • 光疗治疗模式
  • 进行美容护理的次数

第4章 关键成功因素

  • 最近的产品发布
  • 监管场景
  • 光化性角化症与基底细胞癌疾病流行病学（2019年）
  • 製造商的策略促销策略

第5章 全球光动力治疗市场-价格分析

  • 依产品类型进行的区域价格分析
  • 世界平均价格分析基准

第6章 全球光动力治疗市场需求

  • 2019-2023年过去的市值（十亿美元）分析
  • 2024-2031年当前及未来市场价值（十亿美元）预测
    • 年成长趋势分析
    • 绝对的获利机会

第7章 市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第8章 全球光动力治疗市场分析：依产品类型

  • 简介/主要发现
  • 2019-2023年历史市场规模（十亿美元）分析：依产品类型
  • 2024-2031年当前和未来市场规模（十亿美元）的分析和预测：依产品类型
    • 光敏感药物
      • 血卟啉衍生物（HpD）
      • 氨基乙酰丙酸（ALA）
      • 苯并卟啉衍生物（BPD）
      • 泰克沙茶碱
      • 二氢卟酚
      • 染料
    • 设备
      • 抛弃式光纤传输设备
      • 二极体雷射
  • 市场吸引力分析：依产品类型

第9章 全球光动力治疗市场分析：依应用

  • 简介/主要发现
  • 2019-2023年过去的市场规模（十亿美元）分析：依应用
  • 2024-2031年当前和未来市场规模（十亿美元）的分析和预测：依应用
    • 基底细胞癌
    • 日光角化症
    • 其他
      • 牛皮癣
      • 痤疮
      • 酒渣样皮肤炎
      • 非小细胞肺癌
      • 食道癌
      • 眼科
  • 市场吸引力分析：依应用分类

第10章 全球光动力治疗市场分析：依最终使用者

  • 简介/主要发现
  • 2019-2023年历史市场规模（十亿美元）分析：依最终用户
  • 2024-2031年当前和未来市场规模（十亿美元）的分析和预测：依最终用户
    • 医院
    • 私人皮肤科诊所
    • 雷射治疗中心
    • 癌症治疗中心
    • 水疗和恢復中心
  • 市场吸引力分析：依最终用户分类

第11章 北美光动力治疗市场分析

第12章 拉丁美洲光动力治疗市场分析

第13章 欧洲光动力治疗市场分析

第14章 南亚光动力疗法市场分析

第15章 东亚光动力治疗市场分析

第16章 大洋洲光动力治疗市场分析

第17章 中东与非洲光动力治疗市场分析

第18章 新兴国家光动力治疗市场分析

  • 简介
    • 主要国家市值比例分析
    • 世界与国家成长比较
  • 中国光动力治疗市场分析
    • 简介
    • 依市场分类的市场金额比率分析
    • 依市场分类的市场价值（十亿美元）分析和预测
      • 依产品类型
      • 依最终用户
      • 依用途
  • 韩国光动力疗法市场分析
    • 简介
    • 依市场分类的市场金额比率分析
    • 依市场分类的市场价值（十亿美元）分析和预测
      • 依产品类型
      • 依最终用户
      • 依用途
  • 俄罗斯光动力疗法市场分析
    • 简介
    • 价格分析
    • PEST分析
    • 依市场分类的市场金额比率分析
    • 依市场分类的市场价值（十亿美元）分析和预测
      • 依产品类型
      • 依最终用户
      • 依用途
    • 韩国光动力治疗市场 - 竞争格局

第19章 竞争分析

  • 竞争对手仪表板
  • 竞争基准
  • 竞争对手深度分析（光敏药品製造商）
    • Galderma SA
    • Sun Pharmaceutical Industries Ltd.
    • Biofrontera
    • Novartis AG
    • Allergan Plc
  • 对竞争对手（PDT设备製造商）的深入分析
    • Valeant Pharmaceuticals International, Inc
      • 摘要
      • 产品组合
      • 依细分市场的获利能力（产品/通路/区域）
      • 销售基地
      • 策略概述
        • 行销策略
        • 产品策略
        • 通路策略
    • Quest Pharmatech, Inc.
      • 摘要
      • 产品组合
      • 依细分市场的获利能力（产品/通路/区域）
      • 销售基地
      • 策略概述
        • 行销策略
        • 产品策略
        • 通路策略
    • Hologic, Inc.（Cynosure Inc.）
      • 摘要
      • 产品组合
      • 依细分市场的获利能力（产品/通路/区域）
      • 销售基地
      • 策略概述
        • 行销策略
        • 产品策略
        • 通路策略

第20章 使用的假设与缩写

第21章 研究方法

简介目录
Product Code: PMRREP25228

Persistence Market Research has recently released a comprehensive report on the worldwide market for photodynamic therapy (PDT). This report provides an in-depth assessment of essential market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

  • Photodynamic Therapy Market Size (2024): USD 3.5 Bn
  • Projected Market Value (2031): USD 7.4 Bn
  • Global Market Growth Rate (CAGR 2024- 2031): 7.1%

Photodynamic Therapy Market - Report Scope:

Photodynamic therapy plays a crucial role in the treatment of various medical conditions, including certain cancers, age-related macular degeneration (AMD), and precancerous lesions. PDT utilizes light-sensitive drugs and specific wavelengths of light to destroy targeted cells. The photodynamic therapy market serves hospitals, oncology centers, and ophthalmology clinics, offering various therapeutic products and technologies, including photosensitizers, light sources, and delivery systems. Market growth is driven by increasing incidence of cancer and chronic diseases, rising healthcare investments, and advancements in PDT technology, which improve treatment effectiveness and patient outcomes.

Market Growth Drivers:

The global photodynamic therapy market is driven by several key factors, including the growing prevalence of cancer and other chronic conditions requiring effective treatment options. The rising demand for non-invasive and targeted therapies, along with advancements in photosensitizer compounds and light delivery systems, is fostering market expansion. The increasing adoption of PDT in ophthalmology for AMD treatment and the development of novel PDT agents with improved efficacy and reduced side effects are also contributing to market growth. Additionally, expanding healthcare infrastructure and increased research activities in PDT are creating new opportunities for market players.

Market Restraints:

Despite promising growth prospects, the photodynamic therapy market faces challenges related to high treatment costs, limited reimbursement coverage, and potential side effects. The cost of PDT equipment and photosensitizers can be prohibitive for some healthcare systems and patients, particularly in emerging markets with constrained healthcare budgets. Additionally, the limited availability of reimbursement for PDT procedures and concerns about potential adverse effects, such as skin sensitivity and damage, pose challenges for market penetration. Addressing these barriers requires collaboration between industry stakeholders, healthcare providers, and policymakers to improve access and affordability of PDT solutions.

Market Opportunities:

The photodynamic therapy market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving treatment paradigms. The development of advanced photosensitizers with enhanced specificity and reduced systemic toxicity offers new therapeutic possibilities. Moreover, the integration of PDT with other treatment modalities, such as chemotherapy and immunotherapy, is expanding its application scope. The rise of personalized medicine and the increasing focus on early disease detection and treatment are creating new avenues for PDT. Strategic investments in R&D, strategic partnerships, and the introduction of cost-effective PDT solutions are crucial for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the photodynamic therapy market globally?
  • Which PDT applications and technologies are leading the adoption across different medical fields?
  • How are technological advancements and innovations reshaping the competitive landscape of the PDT market?
  • Who are the key players contributing to the photodynamic therapy market, and what strategies are they employing to sustain their market presence?
  • What are the emerging trends and future prospects in the global photodynamic therapy market?

Competitive Intelligence and Business Strategy:

Leading players in the global photodynamic therapy market, including Pfizer Inc., Theralase Technologies Inc., and Galderma S.A., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced PDT products and technologies, including novel photosensitizers, next-generation light delivery systems, and combination therapies. Collaborations with research institutions, healthcare providers, and regulatory bodies facilitate market access and technology adoption. Emphasis on clinical trials, evidence-based practices, and patient education is also crucial for driving market growth and enhancing treatment outcomes in the evolving PDT landscape.

Key Companies Profiled:

  • Givaudan
  • International Flavors & Fragrances Inc
  • MANE
  • Firmenich SA
  • BASF SE
  • Avon Products, Inc.
  • Shiseido Company
  • Limited, Chanel S.A
  • Clarins Fragrance Group
  • COTY INC., LVMH, L'Oreal Group
  • VIORYL S.A.
  • Zanos Ltd.
  • Artiste
  • INDESSO AROMA
  • Aroma Chemical Services International Gmbh

Photodynamic Therapy Market Segmentation

By Product Type

  • Photosensitizer Drugs
  • Photodynamic Therapy Devices

By Application

  • Cancer
  • Skin Conditions

By Region

  • North America
  • Europe
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Disease Epidemiology (2019)
  • 3.2. Patient Treatment Journey
  • 3.3. Phototherapy Treatment Patterns
  • 3.4. Procedure Volume of Cosmetic Therapies

4. Key Success Factors

  • 4.1. Recent Product Launches
  • 4.2. Regulatory Scenario
  • 4.3. Disease Epidemiology For Actinic Keratosis & Basal Cell Carcinoma (2019)
  • 4.4. Strategic Promotional Strategies, By Manufacturers

5. Global Photodynamic Therapy Market - Pricing Analysis

  • 5.1. Regional Pricing Analysis By Product Type
  • 5.2. Global Average Pricing Analysis Benchmark

6. Global Photodynamic Therapy Market Demand (in Value or Size in US$ Bn ) Analysis 2019-2023 and Forecast, 2024 - 2031

  • 6.1. Historical Market Value (US$ Bn ) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Bn ) Projections, 2024 - 2031
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Global GDP Growth Outlook
    • 7.1.2. Global Healthcare Industry Outlook
  • 7.2. Forecast Factors - Relevance & Impact
    • 7.2.1. Recent Product Launches
    • 7.2.2. Prevalence of Skin Disorders and Cancer
    • 7.2.3. Adoption of Photodynamic Therapy For Skin and Cancer Treatment
    • 7.2.4. Top Companies Historical Growth
    • 7.2.5. Per Capita Healthcare Expenditure In Different Economies
  • 7.3. Market Dynamics
    • 7.3.1. Drivers
    • 7.3.2. Restraints
    • 7.3.3. Opportunity Analysis

8. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn ) Analysis By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Product Type, 2024 - 2031
    • 8.3.1. Photosensitizer Drugs
      • 8.3.1.1. Hematoporphyrin derivative (HpD)
      • 8.3.1.2. Aminolevulinic acid (ALA)
      • 8.3.1.3. Benzoporphyrin derivative (BPD)
      • 8.3.1.4. Texaphyrins
      • 8.3.1.5. Chlorins
      • 8.3.1.6. Dyes
    • 8.3.2. Devices
      • 8.3.2.1. Disposable Fiberoptic Light Delivery Devices
      • 8.3.2.2. Diode Laser
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn ) Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Application, 2024 - 2031
    • 9.3.1. Basal Cell Carcinoma
    • 9.3.2. Actinic Keratosis
    • 9.3.3. Others
      • 9.3.3.1. Psoriasis
      • 9.3.3.2. Acne
      • 9.3.3.3. Rosacea
      • 9.3.3.4. Non-Small Cell Lung Cancer
      • 9.3.3.5. Esophageal Cancer
      • 9.3.3.6. Ophthalmology
  • 9.4. Market Attractiveness Analysis By Application

10. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn ) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By End User, 2024 - 2031
    • 10.3.1. Hospitals
    • 10.3.2. Private Dermatology Clinics
    • 10.3.3. Laser Therapy Centers
    • 10.3.4. Cancer Treatment Centers
    • 10.3.5. Spas and Rejuvenation Centers
  • 10.4. Market Attractiveness Analysis By End User

11. North America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
    • 11.4.2. By Product Type
    • 11.4.3. By Application
    • 11.4.4. By End User
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By Application
    • 11.5.4. By End User
  • 11.6. Market Trends

12. Latin America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Rest of Latin America
    • 12.4.2. By Product Type
    • 12.4.3. By Application
    • 12.4.4. By End User
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Application
    • 12.5.4. By End User
  • 12.6. Market Trends

13. Europe Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. Italy
      • 13.4.1.3. France
      • 13.4.1.4. U.K.
      • 13.4.1.5. Spain
      • 13.4.1.6. Russia
      • 13.4.1.7. Poland
      • 13.4.1.8. Rest of Europe
    • 13.4.2. By Product Type
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Application
    • 13.5.4. By End User
  • 13.6. Market Trends

14. South Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
    • 14.4.1. By Country
      • 14.4.1.1. India
      • 14.4.1.2. Thailand
      • 14.4.1.3. Indonesia
      • 14.4.1.4. Malaysia
      • 14.4.1.5. Rest of South Asia
    • 14.4.2. By Product Type
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Market Trends

15. East Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
    • 15.4.2. By Product Type
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Market Trends

16. Oceania Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
    • 16.4.1. By Country
      • 16.4.1.1. Australia
      • 16.4.1.2. New Zealand
    • 16.4.2. By Product Type
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Market Trends

17. Middle East and Africa Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Bn ) Forecast By Market Taxonomy, 2024 - 2031
    • 17.4.1. By Country
      • 17.4.1.1. GCC Countries
      • 17.4.1.2. South Africa
      • 17.4.1.3. Rest of Middle East and Africa
    • 17.4.2. By Product Type
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product Type
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Emerging Countries Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024 - 2031

  • 18.1. Introduction
    • 18.1.1. Market Value Proportion Analysis, By Key Countries
    • 18.1.2. Global Vs. Country Growth Comparison
  • 18.2. China Photodynamic Therapy Market Analysis
    • 18.2.1. Introduction
    • 18.2.2. Market Value Proportion Analysis by Market Taxonomy
    • 18.2.3. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
      • 18.2.3.1. By Product Type
      • 18.2.3.2. By End User
      • 18.2.3.3. By Application
  • 18.3. South Korea Photodynamic Therapy Market Analysis
    • 18.3.1. Introduction
    • 18.3.2. Market Value Proportion Analysis by Market Taxonomy
    • 18.3.3. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
      • 18.3.3.1. By Product Type
      • 18.3.3.2. By End User
      • 18.3.3.3. By Application
  • 18.4. Russia Photodynamic Therapy Market Analysis
    • 18.4.1. Introduction
    • 18.4.2. Pricing Analysis
    • 18.4.3. PEST Analysis
    • 18.4.4. Market Value Proportion Analysis by Market Taxonomy
    • 18.4.5. Market Value (US$ Bn ) Analysis and Forecast by Market Taxonomy
      • 18.4.5.1. By Product Type
      • 18.4.5.2. By End User
      • 18.4.5.3. By Application
    • 18.4.6. South Korea Photodynamic Therapy Market - Competition Landscape

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive (Photosensitizer Drug Manufactures)
    • 19.3.1. Galderma S.A.
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. Strategy Overview
        • 19.3.1.5.1. Marketing Strategy
        • 19.3.1.5.2. Product Strategy
        • 19.3.1.5.3. Channel Strategy
    • 19.3.2. Sun Pharmaceutical Industries Ltd.
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.2.4. Sales Footprint
      • 19.3.2.5. Strategy Overview
        • 19.3.2.5.1. Marketing Strategy
        • 19.3.2.5.2. Product Strategy
        • 19.3.2.5.3. Channel Strategy
    • 19.3.3. Biofrontera
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.3.4. Sales Footprint
      • 19.3.3.5. Strategy Overview
        • 19.3.3.5.1. Marketing Strategy
        • 19.3.3.5.2. Product Strategy
        • 19.3.3.5.3. Channel Strategy
    • 19.3.4. Novartis AG
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.4.4. Sales Footprint
      • 19.3.4.5. Strategy Overview
        • 19.3.4.5.1. Marketing Strategy
        • 19.3.4.5.2. Product Strategy
        • 19.3.4.5.3. Channel Strategy
    • 19.3.5. Allergan Plc
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.5.4. Sales Footprint
      • 19.3.5.5. Strategy Overview
        • 19.3.5.5.1. Marketing Strategy
        • 19.3.5.5.2. Product Strategy
        • 19.3.5.5.3. Channel Strategy
  • 19.4. Competition Deep Dive (PDT Device Manufactures)
    • 19.4.1. Valeant Pharmaceuticals International, Inc.
      • 19.4.1.1. Overview
      • 19.4.1.2. Product Portfolio
      • 19.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.4.1.4. Sales Footprint
      • 19.4.1.5. Strategy Overview
        • 19.4.1.5.1. Marketing Strategy
        • 19.4.1.5.2. Product Strategy
        • 19.4.1.5.3. Channel Strategy
    • 19.4.2. Quest Pharmatech, Inc.
      • 19.4.2.1. Overview
      • 19.4.2.2. Product Portfolio
      • 19.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.4.2.4. Sales Footprint
      • 19.4.2.5. Strategy Overview
        • 19.4.2.5.1. Marketing Strategy
        • 19.4.2.5.2. Product Strategy
        • 19.4.2.5.3. Channel Strategy
    • 19.4.3. Hologic, Inc. (Cynosure Inc.)
      • 19.4.3.1. Overview
      • 19.4.3.2. Product Portfolio
      • 19.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.4.3.4. Sales Footprint
      • 19.4.3.5. Strategy Overview
        • 19.4.3.5.1. Marketing Strategy
        • 19.4.3.5.2. Product Strategy
        • 19.4.3.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology